关于 GLOBEIMMUNE INC
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.
Source: Wikipedia
行业Pharmaceuticals
总部Louisville, CO
成立1995
法律形式C Corporation
状态营业中
专利20 项专利
YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONSJP2019199484A · 2019
IMMUNOTHERAPEUTIC YEAST-MUC1 COMPOSITIONS AND USES THEREOFJP2019194261A · 2019
关键数据
法律信息
| 法定名称 | GLOBEIMMUNE INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1245104在 SEC EDGAR 上查看 ↗ |
| 注册地址 | Louisville, CO |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Nov. 14, 2026